RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
RETA
Delisted
RETA was delisted on the 25th of September, 2023.
158 hedge funds and large institutions have $1.66B invested in Reata Pharmaceuticals, Inc. Class A Common Stock in 2019 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 59 increasing their positions, 47 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
60% less call options, than puts
Call options by funds: $12.6M | Put options by funds: $31.7M
Holders
158
Holding in Top 10
5
Calls
$12.6M
Puts
$31.7M
Top Buyers
| 1 | +$47.6M | |
| 2 | +$21.8M | |
| 3 | +$18.5M | |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$18M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$17M |
Top Sellers
| 1 | -$15.8M | |
| 2 | -$10.7M | |
| 3 | -$6.23M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$5.22M |
| 5 |
PM
Prosight Management
Dallas,
Texas
|
-$4.79M |